“Topical Treatment Utilization for Patients with Atopic Dermatitis in the United States and Budget Impact Analysis of Crisaborole Ointment, 2%”, J of Skin, vol. 1, no. 3.1, p. s43, Oct. 2017, doi: 10.25251/skin.1.supp.42.